BTK Inhibitor Therapy: A Guide For Patients and Their Caregivers

A free resource guide for patients who are receiving BTK inhibitors, including information on FDA approvals, dosing, and potential side effects.
Format: Adobe Acrobat (.pdf)
File Size: 92 KB
Released: June 20, 2019


Jointly provided by Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Alma Perez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)

Supported by educational grants from
Pharmacyclics LLC, an AbbVie Company
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Related Content

John M. Burke, MD, and Shaji Kumar, MD, discuss practice-changing presentations in lymphomas, CLL, and multiple myeloma from ASCO 2019.

John M. Burke, MD Shaji Kumar, MD Physicians: maximum of 1.25 AMA PRA Category 1 Credits Released: August 16, 2019 Expiration: August 15, 2020

Noopur Raje, MD: Clinical impact of latest data for idecabtagene vicleucel (bb2121) and other CAR T-cells in relapsed/refractory multiple myeloma.

Noopur Raje, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: August 16, 2019 Expiration: August 15, 2020

Expert insights from Alessandra Tedeschi, MD, on new data for B-cell malignancy management reported at the 2019 EHA and ICML meetings

person default Alessandra Tedeschi, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: August 13, 2019 Expiration: August 12, 2020

Elisabet E. Manasanch, MD, provides insights on the latest information on the treatment of patients with newly diagnosed myeloma

person default Elisabet E. Manasanch, MD Released: August 9, 2019

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?